Frątczak, A.; Miziołek, B.; Łupicka-Słowik, A.; Sieńczyk, M.; Polak, K.; Bergler-Czop, B.
Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis. Life 2023, 13, 1873.
https://doi.org/10.3390/life13091873
AMA Style
Frątczak A, Miziołek B, Łupicka-Słowik A, Sieńczyk M, Polak K, Bergler-Czop B.
Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis. Life. 2023; 13(9):1873.
https://doi.org/10.3390/life13091873
Chicago/Turabian Style
Frątczak, Aleksandra, Bartosz Miziołek, Agnieszka Łupicka-Słowik, Marcin Sieńczyk, Karina Polak, and Beata Bergler-Czop.
2023. "Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis" Life 13, no. 9: 1873.
https://doi.org/10.3390/life13091873
APA Style
Frątczak, A., Miziołek, B., Łupicka-Słowik, A., Sieńczyk, M., Polak, K., & Bergler-Czop, B.
(2023). Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis. Life, 13(9), 1873.
https://doi.org/10.3390/life13091873
